NEW WHITE PAPER: Solving Atypical Protein Expression with Transposase Technology Dive in today!

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Search

Contact Us

Search

Contact Us

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Our Company

About Us
Our History
Mission & Values
Executive Leadership

Locations

Global Facilities Network
Seattle
Copenhagen
Heidelberg
Milan
Chiba
Yokohama

Policies

Environment, Health & Safety
Group Privacy Policies

Offerings

Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA

Services

Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish Services

Specialized Platforms & Programs

AGCellerate™ mAb & LVV Programs
ProntoLVV™ Lentiviral Vector Platform
BravoAAV™ Adeno-Associated Vector Platform
Proveo™ ADC Program
CMC Jumpstart™ Program

News & Blogs

Press Releases
Biopharma Thought Leadership Blog
Events & Conferences

Resources

Research & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit

Fact Sheet Quick Links

Global cGMP Manufacturing (PDF)
CHEF1^TM Expression Technology (PDF)
Mammalian Capabilities (PDF)
Microbial Capabilities (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)

Join Us

Career Opportunities

What Drives Us

Life at a CDMO
Diversity, Equity and Inclusion

Meet Our Teams

Seattle
Copenhagen
Heidelberg
Milan
Chiba

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Microbial (2)

AGC Biologics recognized as a Børsen Gazelle company of 2022

1 min read

AGC Biologics Copenhagen named Børsen Gazelle company for 2022

February 9, 2023 at 12:00 AM

Mammalian & mAbs Press Release Business Updates Microbial

Read press release

AGC Biologics and Evax partner together.

2 min read

AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate

September 7, 2022 at 2:30 PM

Press Release Business Updates Microbial

Read press release

AGC Biologics honored by American Business Awards

1 min read

AGC Biologics Named Manufacturing Company of the Year by American Business Awards

June 29, 2022 at 6:00 AM

Cell & Gene Therapy Mammalian & mAbs Press Release Business Updates Microbial

Read press release

Prev 1 2

Our Mission

To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.

Links

About Us
Our Services
Locations
Careers
Contact Us
Media Kit

News

Featured Blog Image

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

Authorization clears the way for customers to enter Brazil’s $40 billion pharmaceutical market 

...

Events

Featured Blog Image

DCAT Week 2026 | March 23-27, 2026

Meet our team!

Stop by Hotel 48LEX or email us to learn more about our services and discuss how...

Legal & Compliance

© 2026 AGC Biologics. All Rights Reserved.

AGC Inc. Group